Literature DB >> 24014593

A variant CRISPR-Cas9 system adds versatility to genome engineering.

Ryan M Walsh1, Konrad Hochedlinger.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24014593      PMCID: PMC3785752          DOI: 10.1073/pnas.1314697110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  11 in total

Review 1.  CRISPR/Cas, the immune system of bacteria and archaea.

Authors:  Philippe Horvath; Rodolphe Barrangou
Journal:  Science       Date:  2010-01-08       Impact factor: 47.728

2.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

3.  A TALEN genome-editing system for generating human stem cell-based disease models.

Authors:  Qiurong Ding; Youn-Kyoung Lee; Esperance A K Schaefer; Derek T Peters; Adrian Veres; Kevin Kim; Nicolas Kuperwasser; Daniel L Motola; Torsten B Meissner; William T Hendriks; Marta Trevisan; Rajat M Gupta; Annie Moisan; Eric Banks; Max Friesen; Robert T Schinzel; Fang Xia; Alexander Tang; Yulei Xia; Emmanuel Figueroa; Amy Wann; Tim Ahfeldt; Laurence Daheron; Feng Zhang; Lee L Rubin; Lee F Peng; Raymond T Chung; Kiran Musunuru; Chad A Cowan
Journal:  Cell Stem Cell       Date:  2012-12-13       Impact factor: 24.633

4.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

5.  RNA-guided human genome engineering via Cas9.

Authors:  Prashant Mali; Luhan Yang; Kevin M Esvelt; John Aach; Marc Guell; James E DiCarlo; Julie E Norville; George M Church
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

6.  DNA targeting specificity of RNA-guided Cas9 nucleases.

Authors:  Patrick D Hsu; David A Scott; Joshua A Weinstein; F Ann Ran; Silvana Konermann; Vineeta Agarwala; Yinqing Li; Eli J Fine; Xuebing Wu; Ophir Shalem; Thomas J Cradick; Luciano A Marraffini; Gang Bao; Feng Zhang
Journal:  Nat Biotechnol       Date:  2013-07-21       Impact factor: 54.908

7.  One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

Authors:  Haoyi Wang; Hui Yang; Chikdu S Shivalila; Meelad M Dawlaty; Albert W Cheng; Feng Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2013-05-02       Impact factor: 41.582

8.  CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes.

Authors:  Luke A Gilbert; Matthew H Larson; Leonardo Morsut; Zairan Liu; Gloria A Brar; Sandra E Torres; Noam Stern-Ginossar; Onn Brandman; Evan H Whitehead; Jennifer A Doudna; Wendell A Lim; Jonathan S Weissman; Lei S Qi
Journal:  Cell       Date:  2013-07-11       Impact factor: 41.582

9.  Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.

Authors:  Zhonggang Hou; Yan Zhang; Nicholas E Propson; Sara E Howden; Li-Fang Chu; Erik J Sontheimer; James A Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

10.  High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells.

Authors:  Yanfang Fu; Jennifer A Foden; Cyd Khayter; Morgan L Maeder; Deepak Reyon; J Keith Joung; Jeffry D Sander
Journal:  Nat Biotechnol       Date:  2013-06-23       Impact factor: 54.908

View more
  13 in total

Review 1.  Modulating signaling networks by CRISPR/Cas9-mediated transposable element insertion.

Authors:  Luis María Vaschetto
Journal:  Curr Genet       Date:  2017-10-14       Impact factor: 3.886

Review 2.  Precision genome engineering in lactic acid bacteria.

Authors:  Jan Peter van Pijkeren; Robert A Britton
Journal:  Microb Cell Fact       Date:  2014-08-29       Impact factor: 5.328

3.  Essential function of NHE8 in mouse retina demonstrated by AAV-mediated CRISPR/Cas9 knockdown.

Authors:  Chun-Hong Xia; Ian Ferguson; Mei Li; Audrey Kim; Alex Onishi; Lucy Li; Bonnie Su; Xiaohua Gong
Journal:  Exp Eye Res       Date:  2018-06-26       Impact factor: 3.770

4.  CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences.

Authors:  Sergey V Prykhozhij; Vinothkumar Rajan; Daniel Gaston; Jason N Berman
Journal:  PLoS One       Date:  2015-03-05       Impact factor: 3.240

Review 5.  Post genomics era for orchid research.

Authors:  Wen-Chieh Tsai; Anne Dievart; Chia-Chi Hsu; Yu-Yun Hsiao; Shang-Yi Chiou; Hsin Huang; Hong-Hwa Chen
Journal:  Bot Stud       Date:  2017-12-12       Impact factor: 2.787

6.  CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer.

Authors:  Li-Chi Huang; Ka-Wai Tam; Wei-Ni Liu; Chun-Yu Lin; Kai-Wen Hsu; Wen-Shyang Hsieh; Wei-Ming Chi; Ai-Wei Lee; Jinn-Moon Yang; Ching-Ling Lin; Chia-Hwa Lee
Journal:  Dis Markers       Date:  2018-04-12       Impact factor: 3.434

Review 7.  Genome-editing technologies and their potential application in horticultural crop breeding.

Authors:  Jin-Song Xiong; Jing Ding; Yi Li
Journal:  Hortic Res       Date:  2015-05-13       Impact factor: 6.793

Review 8.  The Rise of CRISPR/Cas for Genome Editing in Stem Cells.

Authors:  Bing Shui; Liz Hernandez Matias; Yi Guo; Ying Peng
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

Review 9.  Current Approaches and Applications in Avian Genome Editing.

Authors:  Joonbum Lee; Dong-Hwan Kim; Kichoon Lee
Journal:  Int J Mol Sci       Date:  2020-05-30       Impact factor: 5.923

Review 10.  CRISPR therapeutic tools for complex genetic disorders and cancer (Review).

Authors:  Stella Baliou; Maria Adamaki; Anthony M Kyriakopoulos; Demetrios A Spandidos; Mihalis Panayiotidis; Ioannis Christodoulou; Vassilis Zoumpourlis
Journal:  Int J Oncol       Date:  2018-06-06       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.